Covid-19 : Russian Sputnik V vaccine approved by Morocco

The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, announced on Wednesday that the Russian vaccine Sputnik V was approved by Morocco. In a press release published on the site dedicated to the vaccine, the fund explained that Sputnik V «has been registered under the emergency use authorization procedure».

Morocco has become the 48th country in the world to authorize the use of Sputnik V.
?https://t.co/di5YCLicJi

— Sputnik V (@sputnikvaccine) March 10, 2021

«Sputnik V is one of the most effective and highly demanded vaccine against coronavirus in the world. It is approved in 48 countries and we appreciate the positive decision by our partners in Morocco», said Kirill Dmitriev, CEO of the Russian sovereign wealth fund.

The same source also lists the advantages of this vaccine developed against Covid-19, recalling that it has an efficacy of  91.6% and it «uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots».

Yesterday, the National Technical and Scientific Advisory Committee on Immunization gave the green light to the Johnson & Johnson and Sputnik V vaccines.